Determination of Intracranial Tumor Volumes in a Rodent Brain Using Magnetic Resonance Imaging, Evans Blue, and Histology: a Comparative Study
Overview
Biophysics
Affiliations
The measurement of tumor volumes is a practical and objective method of assessing the efficacy of a therapeutic agent. However, the relative accuracy of different methods of assessing tumor volume has been unclear. Using T1-weighted, gadolinium-enhanced magnetic resonance Imaging (T1-MRI), Evans Blue infusion and histology we measured intracranial tumor volumes in a rodent brain tumor model (RT2) at days 10, 16 and 18 after implantation of cells in the caudate putamen. There is a good correlation between tumor volumes comparing T1-MRI and Evans Blue (r2 = 0.99), T1-MRI and Histology (r2 = 0.98) and histology and Evans Blue (r2 = 0.93). Each of these methods is reliable in estimating tumor volumes in laboratory animals. There was significant uptake of gadolinium and Evans Blue in the tumor suggesting a wide disruption of the blood-brain barrier.
CHST11-modified chondroitin 4-sulfate as a potential therapeutic target for glioblastoma.
Lin Y, Chu Y, Liao W, Chen C, Hsiao W, Ho Y Am J Cancer Res. 2023; 13(7):2998-3012.
PMID: 37559985 PMC: 10408464.
The Glioma Immune Landscape: A Double-Edged Sword for Treatment Regimens.
Mahajan S, Schmidt M, Schumann U Cancers (Basel). 2023; 15(7).
PMID: 37046685 PMC: 10093409. DOI: 10.3390/cancers15072024.
Blood-Brain Barrier Modulation to Improve Glioma Drug Delivery.
Luo H, Shusta E Pharmaceutics. 2020; 12(11).
PMID: 33198244 PMC: 7697580. DOI: 10.3390/pharmaceutics12111085.
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging.
Geisler J, Spehar J, Steck S, Bratasz A, Shakya R, Powell K J Vis Exp. 2020; (160).
PMID: 32568247 PMC: 8787807. DOI: 10.3791/61272.
Zhao Q, Qu R, Teng L, Yin C, Yuan Y Neuropsychiatr Dis Treat. 2019; 15:1459-1468.
PMID: 31239681 PMC: 6551621. DOI: 10.2147/NDT.S197030.